个人简历

工作经历\r
主任/所长/主任医师/教授，复旦大学附属华山医院普外科、肿瘤转移研究所（2014.1-今）\r
副所长/主任医师/教授，复旦大学附属中山医院肝外科、肝癌研究所（2010.12-2013.12）\r
双聘PI/教授，复旦大学生物医学研究院（2005.5-今）\r
主任医师/教授，复旦大学附属中山医院肝外科、肝癌研究所（2001.12-2010.12）\r
访问学者，香港大学（2000.5-2000.12）\r
访问学者，美国国立卫生研究院（NIH）（1999.1-1999.7）\r
副教授/副主任医师，复旦大学附属中山医院肝外科、肝癌研究所（1996.7-2001.11）\r
讲师/主治医师，徐州医学院附属医院外科（1990.7-1993.8）\r
\r
教育经历\r
博士，上海医科大学，外科学（1993.9-1996.6）\r
硕士，徐州医学院，外科学（1987.9-1990.6）\r
学士，徐州医学院，临床医学系（1982.9-1987.6）

研究领域

"""""主要从事肝癌临床工作与转移复发的机理及防治研究"

近期论文

Ye QH, Zhu WW, Zhang JB, Qin Y, Lu M, Lin GL, Guo L, Zhang B, Lin ZH, Roessler S, Forgues M, Jia HL, Lu L, Zhang XF, Lian BF, Xie L, Dong QZ,Tang ZY, Wang XW, Qin LX. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. Cancer Cell. 2016;30(3):444-58 Preview in Cancer Discovery\r
\r
Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX.MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology. 2014;59(5):1874-85.\r
\r
Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX. MicroRNA-26a Suppresses Tumor Growth and Metastasis of Human Hepatocellular Carcinoma by Targeting IL-6-Stat3 Pathway. Hepatology.2013 J;58(1):158-70.\r
\r
Dong QZ, Zhang XF, Zhao Y, Jia HL, Zhou HJ, Dai C, Sun HJ, Qin Y, Ren N, Ye QH, Qin LX. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology. 2013;57(3):1024-34.\r
\r
Zhu WW, Guo JJ, Guo L, Jia HL, Zhu M, Zhang JB, Loffredo CA, Forgues M, Huang H, Xing XJ, Ren N, Dong QZ, Zhou HJ, Ren ZG, Zhao NQ, Wang XW, Tang ZY, Qin LX*, Ye QH*. Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma. Clin Cancer Res. 2013 Jul 15;19(14):3944-54\r
\r
Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, Jeck WR, Andersen JB, Jiang W, Savich GL, Tan TX, Auman JT, Hoskins JM, Misher AD, Moser CD, Yourstone SM, Kim JW, Cibulskis K, Getz G, Hunt HV, Thorgeirsson SS, Roberts LR, Ye D, Guan KL, Xiong Y*, Qin LX*, Chiang DY*. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene. 2013;32(25):3091-100.\r
\r
Ren N, Wu JC, Dong QZ, Sun HJ, Jia HL, Li GC, Sun BS, Dai C, Shi J, Wei JW, Sheng YY, Zhou HJ, Ye QH and Qin LX. Association of specific enotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma. Cancer Res 2011;71: 3278-86\r
\r
Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX*, Wang XW*. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202-12.\r
\r
Xue YH, Zhang XF, Dong QZ, Sun J, Dai C, Zhou HJ, Ren N, Jia HL, Ye QH, Qin LX.Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma. Hepatology. 2010;52(6):2012-22.\r
\r
Zhou H, Huang H, Shi J, Zhao Y, Dong Q, Jia H, Liu YK, Ye Q, Sun H, Zhu X, Fu L, Guo K, Gao D, Sun J, Yan Z, Ren N, Tang Z, Qin L. Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut 2010;59:1699-1708.\r
\r
Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology. 2008;48(6):1834-42